Kingfa Science & Technology (India) LtdNSE:KINGFA
Current view Q4 2026
India's biggest maker of upgraded high-performance plastics for cars and appliances. A fully-funded new-plant expansion is live, profit margins keep rising yearly, almost no debt, and management delivers what it promises.
Latest exchange filings last 5 · 5 after Q4 2026
- 7 Sep ’26We are enclosing herewith the copies of Newspaper Advertisement pertaining to 42nd Annual General Meeting. ↗
- 6 Sep ’26Kingfa submitted its FY2025-26 BRSR as part of the annual report. ↗
- 5 Sep ’26Reg. 34 (1) Annual Report. 5 Sep ↗
- 5 Sep ’26Board recommended final dividend of Rs20/share for FY2026, payable by 27 October 2026 after AGM approval. ↗
- 5 Sep ’26Company to hold 42nd AGM on 28 Sep 2026; Rs20 dividend record date 21 Sep, payment by 27 Oct. ↗
Exchange filings, with the company's own one-line summary, read off the same page as the figures. Screener publishes only the most recent few, so this is the last 5 — not everything filed since your note, and a quiet-looking list is not proof of a quiet quarter. A filing is marked new when it is dated after the end of the quarter your note covers. Not scored, and not a judgement — a routine repayment notice and a takeover sit in the same list.
AI concall report · Q4 2026
The full earnings-call read behind this view — what management promised, what they delivered, and the earning trigger.
Growth Q4 2026
| Metric | This year vs lastYoY · vs Q4 2025 | vs the quarter beforeQoQ, sequential · vs Q3 2026 | 3-year yearly average3Y CAGR · compounded | 5-year yearly average5Y CAGR · compounded |
|---|---|---|---|---|
| Sales | ▲ +23.0% | +18.2% | +12.4% | +26.1% |
| Operating profit | ▲ +35.0% | +30.6% | +29.4% | +61.1% |
| EPS | ▲ +26.2% | +31.0% | +26.7% | +98.9% |
| PAT | ▲ +40.5% | +31.1% | — | — |
Tinted rows drive the Tier. Tier = the weaker of YoY Sales and YoY PAT growth. Here the weaker is Sales at +23.0%, which is ≥ 20% → Tier 1.
QoQ is sequential, not a trend. For most Indian companies the March quarter is seasonally the largest, so a June-quarter fall against it is a calendar effect. Only the YoY column feeds the Tier.
Multibagger potential
Average56/100
Growing fast — and the market has noticed. Profit per share grew 27% a year, and buyers now pay more for each rupee of it than they did a year ago. Some of the re-pricing has already happened.
₹6,384 → ₹12,768 needs the P/E at 45× — it is 46× today, and has ranged 16× to 81× over the last 5 years. The rest would come from earnings growing as they have.
What you pay for its profitlog scale · 5-year range
Tripling needs 67× — it has traded there — high was 81×.
At ₹4,472 the price-tag on its earnings reaches the 32× it is being projected toward — the point where being cheap against that yardstick is used up.
Re-rated already, on growth that doesn't fully back it.
How this is calculated
This is arithmetic, not a forecast — Return = ΔEPS × ΔMultiple. It says what would have to be true, not how likely it is, and "earnings keep growing at this rate for three more years" is the assumption doing the most work. This is a mid-cap at ₹8,024 cr, so the odds of a re-rate are not fighting its own size.
Growth rate used: 26.7% — the weakest of EPS / Sales / Op-profit from 3-year EPS CAGR. Latest quarter reads 26%.
How it compares with its rivals Capital Goods · 6 of 36 listed
It earns 23% on its capital, more than any of them — the next best earns 21%, and it is the fourth most expensive of the 6 shown.
| Company | Price | P/E | Size | ROCE | Profitlast qtr | Saleslast qtr |
|---|---|---|---|---|---|---|
| Kingfa Science | ₹5,871 | 35.3× | ₹7,956 Cr | 23.2% | +101.6% | +49.1% |
| Supreme Inds. | ₹3,469 | 42.6× | ₹44,068 Cr | 20.7% | +38.8% | +4.2% |
| Astral | ₹1,413 | 64.2× | ₹37,951 Cr | 19.2% | +48.2% | +15.9% |
| Garware Hi Tech | ₹6,671 | 40.0× | ₹15,498 Cr | 18.1% | +59.8% | +27.9% |
| Finolex Inds. | ₹155 | 15.6× | ₹9,602 Cr | 11.8% | +16.7% | −15.3% |
| Time Technoplast | ₹179 | 18.0× | ₹8,841 Cr | 16.5% | +22.2% | +25.1% |
Screener's own peer group, from the request already made for the industry P/E. It serves the industry's largest names by market cap, not companies of a similar size, so treat this as context rather than a like-for-like table; this company is always shown. On a phone the price, size and sales columns are dropped rather than pushed off the edge. Not part of the score.
Business quality to Jun 2026
| Are the margins widening? | broadly flat | operating margin 15% → 16% over 3 years |
|---|---|---|
| Did the profit turn into cash? | under half — much of the profit is tied up | 48% last year, 44% over three · free cash flow −₹45 cr, positive in 3 of 5 years |
| Is the growth borrowed? | essentially debt-free | ₹15 cr — 0.01× its own equity (was 0.06×) |
| Is it being collected? | collection is steady | 98 days to collect, up 5 in a year · cash cycle 100 days |
| Who has been buying? | the promoters have been selling | promoters 67.0% (−8.0 in a year), 75.0% → 67.0% over 2.8 years · FIIs 7.7% (+1.4) · DIIs 8.8% (+8.6) · shareholders 9,419 → 12,293 |
| What does it earn on its capital? | earns a high return on the capital it employs | ROCE 23.2% · ROE 17.4% |
Fetched from the filings, not typed — and deliberately not part of the score. These are the questions the score cannot ask: it reads growth, price and trend, so a company can score well while its profit never becomes cash. Weigh these beside the note, not against the number.
Screener's own checklist not mine, not the score
In its favour
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 103% CAGR over last 5 years
- Company's median sales growth is 16.9% of last 10 years
Against it
- Promoter holding has decreased over last 3 years: -7.97%
Generated by screener.in from a fixed checklist — not written by me and not an input to the score. It is here as a second machine opinion to weigh against the note; where it disagrees with the view above, the note is the considered one.